First Postoperative Day Review After Uneventful Phacoemulsification

The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Phacoemulsification BCVA Complications

Age range

65 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

General Hospital of Veroia

Véroia, Imathia, 59100, Greece

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Exclusion criteria

were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.

Treatment and study plan

Primary outcomes

Best corrected visual acuity

Sponsors and collaborators

Lead sponsor

Veroia General Hospital

Other

Registry information

Important dates

First posted: Nov 24, 2010
Registry last updated: Nov 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed